Immunocore Holdings hired a non-executive director on its board as the company's chief financial officer. The U.K. biotechnology company Thursday said Travis Coy has been appointed CFO and head of ...
This precipitous sell-off has placed Lilly stock near its lowest levels in six months. Below, I'll explore what's been driving the sell-off, and assess whether Lilly has any catalysts that could make ...
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, ...
The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...
Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...
Woman's World on MSN11d
FDA Approves Weight Loss Drug Zepbound To Treat Sleep ApneaGLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...
Stock indexes are mixed in afternoon trading on Wall Street at the start of a holiday-shortened week. The S&P 500 rose 0.6% ...
Stocks closed higher on Wall Street at the start of a holiday-shortened week. The S&P 500 rose 0.7% Monday. Several big ...
After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on ... was being talked about as the next member of the “trillion-dollar club,” a group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback